Is Gut Microbiota a Key Player in Epilepsy Onset? A Longitudinal Study in Drug-Naive Children.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2021
Historique:
received: 29 07 2021
accepted: 16 11 2021
entrez: 20 12 2021
pubmed: 21 12 2021
medline: 28 1 2022
Statut: epublish

Résumé

Microbiota alterations have been recently investigated in individuals with epilepsy and in other neurological diseases as environmental factors that play a role, by acting through the gut-brain axis, in the pathological process. Most studies focus on the contribution of bacterial communities in refractory epilepsy and suggest a beneficial role of ketogenic diet in modulating the gut microbiota and seizure occurrence. However, they do not evaluate whether epilepsy itself alters the gut microbiota in these patients or if the gut microbial communities could contribute as a seizure trigger. In this pilot study, we performed 16S rRNA sequencing and investigated the gut microbial communities of eight children at their seizure onset and after anti-seizure was started (one year follow-up) and we compared microbial data with seven healthy children, age- and sex-matched. In drug-naive subjects, we observed a microbial signature that shared several features with those reported in refractory epilepsy, such as an increased abundance in

Identifiants

pubmed: 34926315
doi: 10.3389/fcimb.2021.749509
pmc: PMC8677705
doi:

Substances chimiques

Pharmaceutical Preparations 0
RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

749509

Informations de copyright

Copyright © 2021 Ceccarani, Viganò, Ottaviano, Redaelli, Severgnini, Vignoli and Borghi.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Neuroinflammation. 2019 Mar 1;16(1):53
pubmed: 30823925
Nat Med. 2010 Apr;16(4):413-9
pubmed: 20348922
Microb Pathog. 2020 Feb;139:103853
pubmed: 31730997
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8075-8083
pubmed: 31599433
Front Microbiol. 2020 Sep 18;11:517797
pubmed: 33042045
Epilepsia. 2021 Feb;62(2):529-541
pubmed: 33428780
Genome Med. 2021 Jan 20;13(1):10
pubmed: 33472701
Scand J Gastroenterol. 1997 Sep;32(9):920-4
pubmed: 9299672
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D277-80
pubmed: 14681412
Epilepsia Open. 2018 Jul 16;3(Suppl Suppl 2):133-142
pubmed: 30564772
Front Microbiol. 2016 Mar 31;7:455
pubmed: 27065999
Neurosci Biobehav Rev. 2019 Dec;107:750-764
pubmed: 31626816
Epilepsy Res. 2021 May;172:106601
pubmed: 33713890
Neurobiol Dis. 2020 Feb;135:104576
pubmed: 31445165
Epilepsy Res. 2018 Sep;145:163-168
pubmed: 30007242
Lancet Neurol. 2020 Feb;19(2):179-194
pubmed: 31753762
Neuroreport. 2000 Jun 5;11(8):1759-63
pubmed: 10852239
BMC Geriatr. 2020 Jul 20;20(1):248
pubmed: 32690030
Epilepsia. 2020 Dec;61(12):2619-2628
pubmed: 33140419
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Appl Environ Microbiol. 2015 Jun;81(11):3655-62
pubmed: 25795669
Gut. 2013 Jan;62(1):159-76
pubmed: 22730468
Gut. 2021 Sep;70(9):1665-1674
pubmed: 33722860
Microorganisms. 2021 Mar 27;9(4):
pubmed: 33801755
Nucleic Acids Res. 2007;35(21):7188-96
pubmed: 17947321
J Endocr Soc. 2020 Feb 20;4(2):bvz039
pubmed: 32099951
BMC Bioinformatics. 2012 Feb 14;13:31
pubmed: 22333067
Gut. 2016 Jan;65(1):57-62
pubmed: 26069274
World J Gastroenterol. 2017 Sep 7;23(33):6164-6171
pubmed: 28970732
Sci Rep. 2019 Sep 27;9(1):13983
pubmed: 31562378
Pathophysiology. 2016 Jun;23(2):67-80
pubmed: 26947707
Cell. 2018 Jul 12;174(2):497
pubmed: 30007420
EBioMedicine. 2019 Jun;44:741-746
pubmed: 31160269
Microb Pathog. 2021 Jun;155:104899
pubmed: 33894293
Neuropsychiatr Dis Treat. 2016 Oct 12;12:2605-2616
pubmed: 27789949
Epilepsy Curr. 2020 Nov-Dec;20(6_suppl):40S-43S
pubmed: 33012196
Metabolites. 2020 Mar 30;10(4):
pubmed: 32235604
Seizure. 2021 Aug;90:80-92
pubmed: 33762166
Expert Rev Neurother. 2019 Oct;19(10):1037-1050
pubmed: 31260640
Front Pediatr. 2019 Oct 01;7:394
pubmed: 31646147
Nat Biotechnol. 2013 Sep;31(9):814-21
pubmed: 23975157
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Int J Mol Sci. 2019 Aug 26;20(17):
pubmed: 31454888
Front Physiol. 2011 Dec 07;2:94
pubmed: 22162969
Pharmacol Res. 2020 Oct;160:105172
pubmed: 32871246
Epilepsia Open. 2018 Apr 09;3(2):290-294
pubmed: 29881810
Epileptic Disord. 2020 Apr 1;22(2):183-193
pubmed: 32301731
NPJ Biofilms Microbiomes. 2019 Jan 23;5(1):5
pubmed: 30701077
J Neuroinflammation. 2018 May 15;15(1):144
pubmed: 29764485

Auteurs

Camilla Ceccarani (C)

Institute of Biomedical Technologies, National Research Council, Segrate, Italy.

Ilaria Viganò (I)

Epilepsy Centre, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo Carlo, University of Milan, Milan, Italy.

Emerenziana Ottaviano (E)

Department of Health Sciences, University of Milan, Milan, Italy.

Maria Gaia Redaelli (MG)

Epilepsy Centre, Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo Carlo, University of Milan, Milan, Italy.

Marco Severgnini (M)

Institute of Biomedical Technologies, National Research Council, Segrate, Italy.

Aglaia Vignoli (A)

Department of Health Sciences, University of Milan, Milan, Italy.
Child Neurology and Psychiatry Unit, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano (ASST GOM) Niguarda, Milan, Italy.

Elisa Borghi (E)

Department of Health Sciences, University of Milan, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH